Updates

Quixant

August 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Ahead of results on 14 September, Quixant said H1 had been strong with EBITDA almost doubling to US$5.8m from US$3.0m including a full six month contribution from Densitron acquired in November. Cash generation has been strong with net debt down US$4.9m from the US$7.9m in December. That puts Quixant in good stead to achieve full year expectations of US$80.2m sales, ebitda of US$13.8m and pretax profit of US$13m (eps of 15.7p). Strong hold. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Empresaria - Buys aviation recruiter

Cohort - Defence firm posts record profits

Quixant (April 2023)

Quixant- Trading materially ahead of expectations (November 2022)

Quixant - Dual catalyst story (October 2021)

Quixant (May 2019)

Quixant - Set to revitalise Densitrons margin (April 2017)

Quixant (January 2017)

Quixant - On course to double sales this year (April 2016)

Quixant - Attractive new issue (July 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X